Cargando…

Expanded Access Programs: Ethical and Practical Considerations for Biopharmaceutical Sponsors

Expanded access is a regulatory mechanism by which an investigational drug can be made available outside of a clinical trial to treat patients with serious or life-threatening conditions for which there are no satisfactory treatment options. An expanded access program (EAP) is the formal plan under...

Descripción completa

Detalles Bibliográficos
Autores principales: Klopfenstein, Mitchell, Van Campen, Luann E., Garnett, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802520/
https://www.ncbi.nlm.nih.gov/pubmed/29473010
http://dx.doi.org/10.1177/2168479015578154

Ejemplares similares